Table 1 from INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
收藏Figshare2026-03-16 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Table_1_from_INDUCE-3_A_Randomized_Phase_II_III_Study_of_First-line_Feladilimab_plus_Pembrolizumab_in_Patients_with_Recurrent_Metastatic_Head_and_Neck_Squamous_Cell_Carcinoma/31744694
下载链接
链接失效反馈官方服务：
资源简介：
Baseline demographics and disease characteristics (mITT population).
创建时间：
2026-03-16
